Mraz Amerine & Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,393
Closed -$283K 210
2026
Q1
$283K Buy
+2,393
New +$296K 0.04% 142
2025
Q4
Sell
-1,512
Closed -$221K 197
2025
Q3
$221K Sell
1,512
-119
-7% -$18K 0.03% 165
2025
Q2
$254K Sell
1,631
-34
-2% -$5.39K 0.04% 162
2025
Q1
$272K Buy
1,665
+23
+1% +$3.83K 0.05% 138
2024
Q4
$268K Sell
1,642
-114
-6% -$20.4K 0.05% 135
2024
Q3
$343K Sell
1,756
-64
-4% -$11.8K 0.06% 123
2024
Q2
$316K Sell
1,820
-97
-5% -$16.1K 0.06% 129
2024
Q1
$324K Sell
1,917
-81
-4% -$15.2K 0.06% 132
2023
Q4
$394K Hold
1,998
0.08% 123
2023
Q3
$348K Hold
1,998
0.08% 125
2023
Q2
$344K Hold
1,998
0.08% 124
2023
Q1
$333K Hold
1,998
0.08% 124
2022
Q4
$293K Hold
1,998
0.07% 138
2022
Q3
$296K Buy
1,998
+26
+1% +$4.34K 0.08% 125
2022
Q2
$339K Sell
1,972
-186
-9% -$32.2K 0.09% 124
2022
Q1
$407K Hold
2,158
0.1% 117
2021
Q4
$527K Sell
2,158
-12
-0.6% -$2.63K 0.14% 97
2021
Q3
$421K Hold
2,170
0.12% 114
2021
Q2
$404K Hold
2,170
0.11% 114
2021
Q1
$342K Hold
2,170
0.1% 115
2020
Q4
$359K Sell
2,170
-96
-4% -$15.6K 0.12% 106
2020
Q3
$375K Hold
2,266
0.14% 84
2020
Q2
$311K Sell
2,266
-234
-9% -$30.6K 0.12% 95
2020
Q1
$294K Hold
2,500
0.12% 94
2019
Q4
$331K Hold
2,500
0.09% 117
2019
Q3
$311K Hold
2,500
0.09% 115
2019
Q2
$284K Hold
2,500
0.08% 127
2019
Q1
$252K Sell
2,500
-586
-19% -$53.2K 0.08% 131
2018
Q4
$264K Hold
3,086
0.09% 124
2018
Q3
$283K Hold
3,086
0.08% 130
2018
Q2
$263K Buy
+3,086
New +$261K 0.08% 133
2018
Q1
Sell
-3,286
Closed -$237K 161
2017
Q4
$237K Hold
3,286
0.07% 130
2017
Q3
$210K Hold
3,286
0.07% 133
2017
Q2
$205K Buy
+3,286
New +$194K 0.06% 138

Other funds holding ZTS

Mraz Amerine & Associates's ZTS Position: Q2 2026 in Review

Mraz Amerine & Associates sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,393 shares — an estimated $283K sold.

Mraz Amerine & Associates first reported a position in ZTS in Q2 2017 and held it in 34 quarters. The position peaked at $527K in Q4 2021. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Mraz Amerine & Associates reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Mraz Amerine & Associates sold 2,393 Zoetis shares in Q2 2026, an estimated $283K.
  • Mraz Amerine & Associates first reported a position in Zoetis in Q2 2017 and held it in 34 quarters.
  • Mraz Amerine & Associates's Zoetis position peaked at $527K in Q4 2021.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.